Ethicon Trial in Dallas Reports Testimony on TVM Dangers
Johnson & Johnson’s Ethicon Prosima device is the center of a trial in progress currently in Dallas. The testimony stated that although medical professionals were aware that there are safer natural alternatives to the mesh product, doctors proceeded to permanently implant a temporary vaginal support device that may be defective. Ethicon’s victims, like Carol Cavness suffered chronic pain, bleeding, tissue erosion, and infections. Patients implanted with Ethicon’s Prosima device risked the need for additional surgeries at a higher risk. The testimony also revealed defects in the Prosima mesh, as well as Ethicon’s failure to provide sufficient instructions and information regarding the side effects, adverse effects, and potential complications. Ethicon responded in court that the pharmaceutical company is not liable, stating that the injuries were caused by pelvic floor disorder unrelated to the Prosima transvaginal mesh surgery. The previous trial in April 2014 resulted in a $1.2 million verdict. A New Jersey court awarded $3.35 million in 2013 in a similar case.